SNDX
Syndax Pharmaceuticals, Inc.Healthcare$25.15
▲ Bullish
Mkt Cap: $2.22B|Float: 74.7M|SI: 27.4%|DTC: 15.1
Data as of market close Apr 2, 2026
IV Rank
83
IV Pctl
78%
HV 20d
54.3%
52W Range
$9-$26
ATR(14)
$1.18
Exp. Move
±14.8%
P/C Ratio
0.41
Earnings
May 4
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
SNDX Key Options Data
- IV Rank
- 82.6%
- Total GEX
- $0.00B
- Total DEX
- $0.8M
- Max Pain
- $22.00
- Expected Move
- ±14.8%
- Put/Call OI
- 0.41
- Net Premium
- $0.2M
- Spot Price
- $25.15
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$3.73 | ±14.8% | $21.42 | $28.87 |
| 2026-05-15 | 43 | ±$2.65 | ±10.5% | $22.50 | $27.80 |
| 2026-07-17 | 106 | ±$8.35 | ±33.2% | $16.80 | $33.50 |
| 2026-08-21 | 141 | ±$4.15 | ±16.5% | $21.00 | $29.30 |
| 2026-09-18 | 169 | ±$5.45 | ±21.7% | $19.70 | $30.60 |
| 2026-10-16 | 197 | ±$5.40 | ±21.5% | $19.75 | $30.55 |
Explore SNDX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.